Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II, Multicenter, Single-Arm Study of Pemigatinib in Patients With Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04096417
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:57.551343+00:00
Published At
2024-02-21T00:00:00+00:00
Record Updated At
2024-02-21
Results Posted At
2024-02-21
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["FGFR1 Gene Amplification", "FGFR1 Gene Mutation", "FGFR1 Gene Translocation", "FGFR2 Gene Amplification", "FGFR2 Gene Mutation", "FGFR2 Gene Translocation", "FGFR3 Gene Amplification", "FGFR3 Gene Mutation", "FGFR3 Gene Translocation", "Metastatic Colorectal Carcinoma", "Stage III Colorectal Cancer AJCC v8", "Stage IIIA Colorectal Cancer AJCC v8", "Stage IIIB Colorectal Cancer AJCC v8", "Stage IIIC Colorectal Cancer AJCC v8", "Stage IV Colorectal Cancer AJCC v8", "Stage IVA Colorectal Cancer AJCC v8", "Stage IVB Colorectal Cancer AJCC v8", "Stage IVC Colorectal Cancer AJCC v8", "Unresectable Colorectal Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-02-21"
protocolSection.identificationModule.nctId
"NCT04096417"
protocolSection.identificationModule.officialTitle
"A Phase II, Multicenter, Single-Arm Study of Pemigatinib in Patients With Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2024-02-21"

Study condition terms

  • FGFR1 Gene Amplification (protocolSection.conditionsModule.conditions)
  • FGFR1 Gene Mutation (protocolSection.conditionsModule.conditions)
  • FGFR1 Gene Translocation (protocolSection.conditionsModule.conditions)
  • FGFR2 Gene Amplification (protocolSection.conditionsModule.conditions)
  • FGFR2 Gene Mutation (protocolSection.conditionsModule.conditions)
  • FGFR2 Gene Translocation (protocolSection.conditionsModule.conditions)
  • FGFR3 Gene Amplification (protocolSection.conditionsModule.conditions)
  • FGFR3 Gene Mutation (protocolSection.conditionsModule.conditions)
  • FGFR3 Gene Translocation (protocolSection.conditionsModule.conditions)
  • Metastatic Colorectal Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Colorectal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Colorectal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Colorectal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIC Colorectal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Colorectal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Colorectal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Colorectal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVC Colorectal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Unresectable Colorectal Carcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.